Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | MDM2 | Q00987 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | CASP7 | P55210 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.67 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrofurantoin SCHEMBL29471 | 1.00 | LMNA (1.00) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL2508426 | 1.00 | LMNA (1.00) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL29470 | 1.00 | LMNA (1.00) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL668258 | 0.99 | LMNA (0.97) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL547326 | 0.99 | LMNA (0.97) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL3339581 | 0.99 | LMNA (0.97) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL9813751 | 0.99 | LMNA (0.97) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL3339573 | 0.99 | LMNA (0.97) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL2323795 | 0.90 | LMNA (0.81) | LMNAMAPTTDP1TP53MDM2 | |
| Nitrofurantoin SCHEMBL2323793 | 0.90 | LMNA (0.81) | LMNAMAPTTDP1TP53MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 25876 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107208-A1 | COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS | THE METHODIST HOSPITAL (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4743122-A1 | THERAPEUTIC SEALANTS BASED UPON DRUG CONJUGATES | The Johns Hopkins University (US) | 2026-05-20 | — | — | EP | claimed |
| EP-4743153-A1 | MEDICAL SYSTEMS FOR TREATING CONDITIONS AND DISEASES OF THE PATIENT'S BODY CAVITIES | UTT Urine Topical Treatment Ltd (IL) | 2026-05-20 | — | — | EP | claimed |
| EP-4225277-B1 | MESOPOROUS NANOPARTICLE SYSTEM TO INCREASE THE BIOFILM ERADICATION ACTIVITY BY MEANS OF THE CARRYING AND THE ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT AND RELATED PRODUCTION METHOD | BRENTA S R L (IT) | 2026-05-13 | — | — | EP | claimed |
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| EP-0078079-A2 | Nitrofurantoin dosage form | Norwich Eaton Pharmaceuticals, Inc. (US) | 1983-05-04 | — | — | EP | claimed |
| US-4370313-A | COATED WITH ACRYLIC RESIN | EATON LABORATORIES, INC. (US) | 1983-01-25 | — | — | US | claimed |
| EP-0069385-A2 | Use of eucalyptol for enhancing skin permeation of bioaffecting agents | MERCK & CO. INC. (US) | 1983-01-12 | — | — | EP | claimed |
| EP-0036138-A2 | Composition of matter for topical application comprising a bio-affecting agent and N,N-diethyl-m-toluamide | MERCK & CO. INC. (US) | 1981-09-23 | — | — | EP | claimed |
| US-4288543-A | SAMPLING IN LIQUID PHASE WITH ANTIGROWTH AGENTS-BIOLOGICAL | PFIZER INC. (US) | 1981-09-08 | — | — | US | claimed |
| US-4191772-A | Instillation composition | BOEHRINGER MANNHEIM GMBH (DE) | 1980-03-04 | — | — | US | claimed |
| US-4152444-A | RIFAMPICIN AND NITROFURANTOIN | CIBA-GEIGY CORPORATION (US) | 1979-05-01 | — | — | US | claimed |
| US-4122157-A | TREATMENT OF URINARY TRACT INFECTIONS | RICHARDSON-MERRELL INC. (US) | 1978-10-24 | — | — | US | claimed |
| US-4053593-A | PREVENTING AND CURING DISEASES IN FISH | FRUMOFF LEW | 1977-10-11 | — | — | US | claimed |